Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme.Damodar Bachani, K Sujatha Rao, Renu Garg et al.|PubMed|2010Cited by 75
AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 TrialSakib Burza, Krishna Pandey, Estrella Lasry et al.|Clinical Infectious Diseases|2022Cited by 53
Evaluating Patients for Second-Line Antiretroviral Therapy in India: The Role of Targeted Viral Load TestingBharat Rewari, Padmini Srikantiah, Polin Chan et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2010Cited by 21